Drug
Adalimumab-ryvk
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Drug Effect Less Than Expected | 36 | 58.7 | 61.1 | signal |
| 2 | Insurance Issue | 34 | 52.6 | 54.6 | signal |
| 3 | Ankylosing Spondylitis | 26 | 45.9 | 47.2 | signal |
| 4 | Uveitis | 24 | 40.8 | 41.9 | signal |
| 5 | Drug Level Decreased | 14 | 31.4 | 31.9 | signal |
| 6 | Colitis Ulcerative | 38 | 19.6 | 20.4 | signal |
| 7 | Psoriatic Arthropathy | 31 | 17.7 | 18.3 | signal |
| 8 | Abscess | 12 | 17.3 | 17.5 | signal |
| 9 | Impaired Quality Of Life | 10 | 16.0 | 16.1 | signal |
| 10 | Intentional Dose Omission | 19 | 15.9 | 16.3 | signal |
| 11 | Rheumatoid Arthritis | 71 | 14.4 | 15.5 | signal |
| 12 | Frequent Bowel Movements | 15 | 12.8 | 13.0 | signal |
| 13 | Fistula | 6 | 12.2 | 12.3 | signal |
| 14 | Inappropriate Schedule Of Product Administration | 88 | 11.4 | 12.5 | signal |
| 15 | Haematochezia | 26 | 10.8 | 11.1 | signal |
| 16 | Product Substitution Issue | 26 | 10.4 | 10.6 | signal |
| 17 | Therapy Interrupted | 30 | 10.0 | 10.3 | signal |
| 18 | Surgery | 25 | 9.9 | 10.1 | signal |
| 19 | Spinal Operation | 5 | 9.5 | 9.5 | signal |
| 20 | Inflammatory Bowel Disease | 4 | 9.3 | 9.4 | signal |
| 21 | Product Administration Error | 8 | 9.2 | 9.3 | signal |
| 22 | Product Dose Omission Issue | 113 | 9.1 | 10.3 | signal |
| 23 | Complication Associated With Device | 5 | 8.7 | 8.7 | signal |
| 24 | Sars-cov-2 Test Positive | 5 | 8.6 | 8.6 | signal |
| 25 | Injection Site Pruritus | 22 | 7.6 | 7.7 | signal |
| 26 | Injection Site Urticaria | 8 | 7.6 | 7.6 | signal |
| 27 | Nerve Compression | 3 | 7.5 | 7.5 | signal |
| 28 | Abdominal Pain Lower | 8 | 7.2 | 7.3 | signal |
| 29 | Device Malfunction | 21 | 7.2 | 7.3 | signal |
| 30 | Therapy Change | 3 | 7.1 | 7.2 | signal |
| 31 | Exposure During Pregnancy | 17 | 6.3 | 6.4 | signal |
| 32 | Sleep Disorder Due To A General Medical Condition | 4 | 5.7 | 5.7 | signal |
| 33 | Injection Site Mass | 9 | 5.6 | 5.6 | signal |
| 34 | Injection Site Erythema | 27 | 5.0 | 5.1 | signal |
| 35 | Injection Site Rash | 6 | 4.5 | 4.6 | signal |
| 36 | Injection Site Warmth | 4 | 4.5 | 4.5 | signal |
| 37 | Wrong Technique In Device Usage Process | 8 | 4.0 | 4.0 | signal |
| 38 | Injection Site Swelling | 12 | 3.6 | 3.7 | signal |
| 39 | Psoriasis | 20 | 3.5 | 3.6 | signal |
| 40 | Injection Site Pain | 45 | 3.4 | 3.5 | signal |
| 41 | Incorrect Dose Administered By Device | 3 | 2.7 | 2.7 | no signal |
| 42 | Product Storage Error | 10 | 2.7 | 2.7 | signal |
| 43 | Injection Site Haemorrhage | 8 | 2.3 | 2.3 | signal |